Skip to main content
SpringerLink
Log in

Case report: successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine

  • Letter to the Editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Calabrese JR, Bowden CL, Sachs GS et al. (1999) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60:79–88

    CAS  PubMed  Google Scholar 

  • Calabrese JR, Sullivan JR, Bowden CL et al. (2002) Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry 63:1012–1019

    PubMed  Google Scholar 

  • Ghaemi SN, Hsu DJ, Soldani F et al. (2003) Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 5:421–433

    Article  PubMed  Google Scholar 

  • Goodwin GM (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17:149–173; discussion 147

    Article  CAS  PubMed  Google Scholar 

  • Goodwin,FK, Jamison KR (1990) Manic-depressive Illness. Oxford University Press, New York

  • Keck J, Paul E, Nelson EB, McElroy SL (2003) Advances in the pharmacologic treatment of bipolar depression. Biol Psychiatry 53:671–679

    Article  CAS  PubMed  Google Scholar 

  • Prakriya M, Mennerick S (2000) Selective depression of low-release probability excitatory synapses by sodium channel blockers. Neuron 26:671–682

    CAS  PubMed  Google Scholar 

  • Simpson SG, Jamison KR (1999) The risk of suicide in patients with bipolar disorders. J Clin Psychiatry 60 (Suppl 2):53–56; discussion 75–76, 113–116

    Google Scholar 

  • Zarate CA Jr, Payne JL, Quiroz JA, Sporn J, Denicoff KD, Luckenbaugh D, Charney DS, Manji HK (2004) An open-label trial of riluzole in treatment-resistant major depression. Am J Psychiatry 161:171–174

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Molecular Pathophysiology, National Institutes of Mental Health, Building 10, Room 3s242, 9000 Rockville Pike, Bethesda, MD 20892, USA

    Jaskaran Singh & Carlos A. Zarate Jr

  2. Duke University Medical Center, Box 3309, Durham, NC 27708, USA

    Andrew D. Krystal

Authors
  1. Jaskaran Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos A. Zarate Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew D. Krystal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaskaran Singh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Singh, J., Zarate, C.A. & Krystal, A.D. Case report: successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine. Psychopharmacology 173, 227–228 (2004). https://doi.org/10.1007/s00213-003-1756-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1756-8

Keywords

Search

Navigation